Here is Matt Lowdon‘s weekly funding update covering news across medtech and biotech. CAR-T, longevity research, nerve stimulation and more. Congratulations to all involved. ➡️ Cancer immunotherapy company Liminatus Pharma, Inc has agreed to pay out shares worth $320m to buy CAR-T…
Read MoreMonth: May 2026

